Abstract
Partneringreview 2006 -- Volume 4: Stage of Development provides an in depth
view into the deals and alliances by development stage announced in 2005, in a
clear and accessible format. The report reviews over 2,600 deal
announcements from discovery stage deals to marketed -- the full list of
stages covered -- discovery, lead molecule, preclinical, phase I, phase I/II,
phase II, phase II/III, pre-registration, regulatory approval, marketing and
formulation stage deals. Each sector is further divided to analyze deals by
company, industry sector and therapy area. Every deal is fully
categorized, includes a detailed description, and includes financials such as
headline value, upfront and milestone payments, where disclosed.
Each deal is annotated with a deal number, such as #43. This number links to
the full deal in the deal listing at the rear of each report. When using the
PDF format in Acrobat Reader, simply click on the number to move around the
report.
All the year's deals at a glance.
Want to know what your competitors are doing? Want to benchmark your deals
against others in your therapeutic area or see how the finances of different
deal types compare? Partneringreview 2006 brings all the 2005's deals into
focus in one place.
Partneringreview is a comprehensive summary of the year's deal announcements
in a clear and accessible printable format. Every deal entry includes
financial information where disclosed, such as headline values and upfront and
milestone payments. A new addition of an overview of financings from investors
is also included in this latest edition.
Partneringreview 2006 is the full report of all the deals data collected in
2005, providing a broad perspective of deal announcements, and incorporates
all six volumes.
Table of Contents
INTRODUCTION
- About Partneringreview
- Full contents of Partneringreview 2006
- Review of deal making in 2005
- Deals announced by development stage
VOLUME 4: STAGE OF DEVELOPMENT
Chapter 1: Early stage -- discovery, lead and preclinical
- Deals in early stage by company
- Deals in early stage by industry focus
- Deals in early stage by therapy focus
Chapter 2: Clinical stage - phase I to Phase III
- Deals in clinical stage by company
- Deals in clinical stage by industry focus
- Deals in clinical stage by therapy focus
Chapter 3: Late stage -- registration, approval and marketed
- Deals in late stage by company
- Deals in late stage by industry focus
- Deals in late stage by therapy focus
Chapter 4: List of deals
GLOSSARY
Tables
- Table 1 Top early stage type dealmaking companies in 2005
- Table 2 Top clinical stage type dealmaking companies in 2005
- Table 3 Top late stage type dealmaking companies in 2005
Figures
- Fig. i.1 Deals announced by stage
- Fig. 1.1 Announcements in early stage by company
- Fig. 1.2 Announcements in early stage by industry sector
- Fig. 1.3 Announcements in early stage by therapy area
- Fig. 2.1 Announcements in clinical stage by company
- Fig. 2.2 Announcements in clinical stage by industry sector
- Fig. 2.3 Announcements in clinical stage by therapy area
- Fig. 3.1 Announcements in late stage by company
- Fig. 3.2 Announcements in late stage by industry sector
- Fig. 3.3 Announcements in late stage by therapy area
